CRISPR as a Diagnostic Tool

Biomolecules. 2021 Aug 6;11(8):1162. doi: 10.3390/biom11081162.

Abstract

Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas system has recently gained growing attention as a diagnostic tool due to its capability of specific gene targeting. It consists of Cas enzymes and a guide RNA (gRNA) that can cleave the target DNA or RNA based on the sequence of the gRNA, making it an attractive genetic engineering technique. In addition to the target-specific binding and cleavage, the trans-cleavage activity was reported for some Cas proteins, including Cas12a and Cas13a, which is to cleave the surrounding single-stranded DNA or RNA upon the target binding of Cas-gRNA complex. All these activities of the CRISPR-Cas system are based on its target-specific binding, making it applied to develop diagnostic methods by detecting the disease-related gene as well as microRNAs and the genetic variations such as single nucleotide polymorphism and DNA methylation. Moreover, it can be applied to detect the non-nucleic acids target such as proteins. In this review, we cover the various CRISPR-based diagnostic methods by focusing on the activity of the CRISPR-Cas system and the form of the target. The CRISPR-based diagnostic methods without target amplification are also introduced briefly.

Keywords: CRISPR-Cas; DNA methylation; aptamer; diagnosis; gene detection; microRNA; single nucleotide polymorphism.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aptamers, Nucleotide / genetics
  • Aptamers, Nucleotide / metabolism
  • Autoimmune Diseases / diagnosis
  • Autoimmune Diseases / genetics
  • Autoimmune Diseases / metabolism
  • Autoimmune Diseases / therapy*
  • CRISPR-Associated Protein 9 / genetics
  • CRISPR-Associated Protein 9 / metabolism
  • CRISPR-Cas Systems*
  • Clustered Regularly Interspaced Short Palindromic Repeats*
  • DNA Methylation
  • DNA, Single-Stranded / genetics
  • DNA, Single-Stranded / metabolism
  • Gene Editing / methods*
  • Genetic Engineering / methods
  • Humans
  • MicroRNAs / genetics
  • MicroRNAs / metabolism
  • Molecular Targeted Therapy / methods*
  • Neoplasms / diagnosis
  • Neoplasms / genetics
  • Neoplasms / metabolism
  • Neoplasms / therapy*
  • Polymorphism, Single Nucleotide
  • RNA, Guide, CRISPR-Cas Systems / genetics
  • RNA, Guide, CRISPR-Cas Systems / metabolism

Substances

  • Aptamers, Nucleotide
  • DNA, Single-Stranded
  • MicroRNAs
  • RNA, Guide, CRISPR-Cas Systems
  • CRISPR-Associated Protein 9